Fujirebio Diagnostics Inc:企業の製品パイプライン分析

◆英語タイトル:Fujirebio Diagnostics Inc - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME2171PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥210,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥315,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fujirebio Diagnostics Inc (FDI), a subsidiary of Fujirebio Inc is a healthcare diagnostic company that manufactures, markets and develops biomarker assays and in-vitro diagnostic products. The company’s products include OEM custom solutions, manual kits, serum products, multi-constituent controls, EIA kits, and other test kits, among others. Its serum products comprise enzyme conjugate stabilizer, glycated human hemoglobin animal serums, and nonglycated human haemoglobin, among others. FDI also provides reagents and controls, and manual assay products, among others. The company offers elisa antibody and antigen kits. It has its operations through its offices located in the US, Italy and Russia. FDI is headquartered in Malvern, Pennsylvania, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Fujirebio Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Fujirebio Diagnostics Inc Company Overview
Fujirebio Diagnostics Inc Company Snapshot
Fujirebio Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Fujirebio Diagnostics Inc – Pipeline Analysis Overview
Fujirebio Diagnostics Inc – Key Facts
Fujirebio Diagnostics Inc – Major Products and Services
Fujirebio Diagnostics Inc Pipeline Products by Development Stage
Fujirebio Diagnostics Inc Pipeline Products Overview
Lumipulse G – ApoB48 Assay Kit
Lumipulse G – ApoB48 Assay Kit Product Overview
Lumipulse G – HAVAb Assay Kit
Lumipulse G – HAVAb Assay Kit Product Overview
Lumipulse G – HBsAb Assay Kit
Lumipulse G – HBsAb Assay Kit Product Overview
Lumipulse G – HBsAg-Qualitative Assay Kit
Lumipulse G – HBsAg-Qualitative Assay Kit Product Overview
Lumipulse G – HBsAg-Quant Confirmation Assay Kit
Lumipulse G – HBsAg-Quant Confirmation Assay Kit Product Overview
Lumipulse G – HCV Ab Assay Kit
Lumipulse G – HCV Ab Assay Kit Product Overview
Lumipulse G – HCV Ag Assay Kit
Lumipulse G – HCV Ag Assay Kit Product Overview
Lumipulse G – HIV 1/2 Assay Kit
Lumipulse G – HIV 1/2 Assay Kit Product Overview
Lumipulse G – HIV-1p24 Assay Kit
Lumipulse G – HIV-1p24 Assay Kit Product Overview
Lumipulse G – HIVAg/Ab Assay Kit
Lumipulse G – HIVAg/Ab Assay Kit Product Overview
Lumipulse G – HTLV-l Assay Kit
Lumipulse G – HTLV-l Assay Kit Product Overview
Lumipulse G – L- FABP Assay
Lumipulse G – L- FABP Assay Product Overview
Lumipulse G – NCC-ST439 Assay
Lumipulse G – NCC-ST439 Assay Product Overview
Lumipulse G – PLAP Assay Kit
Lumipulse G – PLAP Assay Kit Product Overview
Lumipulse G C-Peptide Assay Kit
Lumipulse G C-Peptide Assay Kit Product Overview
Lumipulse G Mesothelin Assay
Lumipulse G Mesothelin Assay Product Overview
Lumipulse G ß-Amyloid Ratio (1-42/1-40)
Lumipulse G ß-Amyloid Ratio (1-42/1-40) Product Overview
Lumipulse G1200 – AMH
Lumipulse G1200 – AMH Product Overview
Lumipulse G1200 – Estradiol Assay
Lumipulse G1200 – Estradiol Assay Product Overview
Lumipulse G1200 – pTAU
Lumipulse G1200 – pTAU Product Overview
Lumipulse G1200 – ß-amyloid 1-42
Lumipulse G1200 – ß-amyloid 1-42 Product Overview
Lumipulse G1200 – Total TAU
Lumipulse G1200 – Total TAU Product Overview
Lumipulse SARS CoV-2 Antigen Assay
Lumipulse SARS CoV-2 Antigen Assay Product Overview
Fujirebio Diagnostics Inc – Key Competitors
Fujirebio Diagnostics Inc – Key Employees
Fujirebio Diagnostics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Fujirebio Diagnostics Inc, Recent Developments
Jun 12, 2018: Fujirebio Diagnostics Announces FDA Clearance of Lumipulse G B•R•A•H•M•S PCT Assay
Apr 05, 2017: Fujirebio Europe Launches Lumipulse G HTLV-I/II for Fully Automated Screening of HTLV-I/II Viral Infection
Feb 19, 2016: Fujirebio Europe Launches Lumipulse G Mesothelin, The First Fully Automated Immunoassay to Aid in the Diagnosis of Malignant Mesothelioma
Jan 11, 2016: Fujirebio Europe launches Lumipulse G B•R•A•H•M•S PCT for fully automated testing on theLUMIPULSE G series
Jun 18, 2015: Fujirebio Europe Releases The Lumipulse G He4 Assay Dedicated To Ovarian Cancer Therapy Monitoring And Conservative Management Of Women With Pelvic Mass
Sep 06, 2011: Fujirebio Receives FDA 510 (k) Clearance For ROMA (HE4 EIA + ARCHITECT CA 125 II) Test To Monitor Ovarian Cancer
Jun 06, 2011: Fujirebio Reports New Publication Validates Use Of HE4 In Evaluating Risk Of Ovarian Cancer
May 31, 2011: Fujirebio Receives FDA 510 (k) Clearance For CYFRA 21-1 EIA Assay To Monitor Lung Cancer
Mar 23, 2009: Fujirebio Diagnostics Appoints Grady Barnes As CSO
Feb 11, 2009: Fujirebio Diagnostics` Risk Of Ovarian Malignancy Algorithm(ROMA) In Combination With Biomarker Demonstrates Accuracy In Detecting Ovarian Cancer
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Fujirebio Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Fujirebio Diagnostics Inc Pipeline Products by Equipment Type
Fujirebio Diagnostics Inc Pipeline Products by Indication
Fujirebio Diagnostics Inc, Key Facts
Fujirebio Diagnostics Inc, Major Products and Services
Fujirebio Diagnostics Inc Number of Pipeline Products by Development Stage
Fujirebio Diagnostics Inc Pipeline Products Summary by Development Stage
Lumipulse G - ApoB48 Assay Kit - Product Status
Lumipulse G - ApoB48 Assay Kit - Product Description
Lumipulse G - HAVAb Assay Kit - Product Status
Lumipulse G - HAVAb Assay Kit - Product Description
Lumipulse G - HBsAb Assay Kit - Product Status
Lumipulse G - HBsAb Assay Kit - Product Description
Lumipulse G - HBsAg-Qualitative Assay Kit - Product Status
Lumipulse G - HBsAg-Qualitative Assay Kit - Product Description
Lumipulse G - HBsAg-Quant Confirmation Assay Kit - Product Status
Lumipulse G - HBsAg-Quant Confirmation Assay Kit - Product Description
Lumipulse G - HCV Ab Assay Kit - Product Status
Lumipulse G - HCV Ab Assay Kit - Product Description
Lumipulse G - HCV Ag Assay Kit - Product Status
Lumipulse G - HCV Ag Assay Kit - Product Description
Lumipulse G - HIV 1/2 Assay Kit - Product Status
Lumipulse G - HIV 1/2 Assay Kit - Product Description
Lumipulse G - HIV-1p24 Assay Kit - Product Status
Lumipulse G - HIV-1p24 Assay Kit - Product Description
Lumipulse G - HIVAg/Ab Assay Kit - Product Status
Lumipulse G - HIVAg/Ab Assay Kit - Product Description
Lumipulse G - HTLV-l Assay Kit - Product Status
Lumipulse G - HTLV-l Assay Kit - Product Description
Lumipulse G - L- FABP Assay - Product Status
Lumipulse G - L- FABP Assay - Product Description
Lumipulse G - NCC-ST439 Assay - Product Status
Lumipulse G - NCC-ST439 Assay - Product Description
Lumipulse G - PLAP Assay Kit - Product Status
Lumipulse G - PLAP Assay Kit - Product Description
Lumipulse G C-Peptide Assay Kit - Product Status
Lumipulse G C-Peptide Assay Kit - Product Description
Lumipulse G Mesothelin Assay - Product Status
Lumipulse G Mesothelin Assay - Product Description
Lumipulse G ß-Amyloid Ratio (1-42/1-40) - Product Status
Lumipulse G ß-Amyloid Ratio (1-42/1-40) - Product Description
Lumipulse G1200 - AMH - Product Status
Lumipulse G1200 - AMH - Product Description
Lumipulse G1200 - Estradiol Assay - Product Status
Lumipulse G1200 - Estradiol Assay - Product Description
Lumipulse G1200 - pTAU - Product Status
Lumipulse G1200 - pTAU - Product Description
Lumipulse G1200 - ß-amyloid 1-42 - Product Status
Lumipulse G1200 - ß-amyloid 1-42 - Product Description
Lumipulse G1200 - Total TAU - Product Status
Lumipulse G1200 - Total TAU - Product Description
Lumipulse SARS CoV-2 Antigen Assay - Product Status
Lumipulse SARS CoV-2 Antigen Assay - Product Description
Fujirebio Diagnostics Inc, Key Employees
Fujirebio Diagnostics Inc, Subsidiaries
Glossary

★海外企業調査レポート[Fujirebio Diagnostics Inc:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wartsila Corp (WRT1V):企業の財務・戦略的SWOT分析
    Wartsila Corp (WRT1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Aslan Pharmaceuticals Pte Ltd (6497):製薬・医療:M&Aディール及び事業提携情報
    Summary Aslan Pharmaceuticals Pte Ltd (Aslan), a subsidiary of Aslan Pharmaceuticals Ltd, is a biotechnology company that offers immuno-oncology agents and targeted therapies. The company’s pipeline products comprise varlitinib, ASLAN002, ASLAN003 and ASLAN004. Its ASLAN002 is a small molecule inhib …
  • Ipsen S.A.:企業の戦略・SWOT・財務情報
    Ipsen S.A. - Strategy, SWOT and Corporate Finance Report Summary Ipsen S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Noble Group Ltd:戦略・SWOT・企業財務分析
    Noble Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Noble Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Kansas City Power & Light Co:電力:M&Aディール及び事業提携情報
    Summary Kansas City Power & Light Co. (KCP&L), a subsidiary of Great Plains Energy, Inc., is an integrated energy utility that generates, transmits, distributes, and sells electricity. The company generates electricity from nuclear, solar, biogas, wind, hydro, coal, and natural gas sources. Through …
  • Corpak MedSystems Inc-医療機器分野:企業M&A・提携分析
    Summary Corpak MedSystems Inc (Corpak), a subsidiary of Halyard Health Inc is a medical device company that manufactures and markets enteral feeding safety devices. The company offers products such as cortrak systems, gastrostomy, nasoenteric systems, gastric decompression, NICU products and accesso …
  • The Scotts Miracle-Gro Company (SMG):企業の財務・戦略的SWOT分析
    The Scotts Miracle-Gro Company (SMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Biogen, Inc.:企業のM&A・事業提携・投資動向
    Biogen, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Biogen, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • MedNet Solutions Inc-医療機器分野:企業M&A・提携分析
    Summary MedNet Solutions Inc (MedNet Solutions) is a healthcare technology company which provides eClinical and electronic data capture software solutions. The company developed iMedNet, an eClinical technology platform which provides non – technical clinical research for clinical trials or studies. …
  • athenahealth Inc (ATHN):製薬・医療:M&Aディール及び事業提携情報
    Summary athenahealth Inc (athenahealth) is a provider of cloud-based business services and mobile applications for medical groups and health system. The company offers network-enabled services for revenue cycle management and medical billing, electronic health records (EHR), patient engagement, popu …
  • Nihon Unisys, Ltd.:企業の戦略・SWOT・財務情報
    Nihon Unisys, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nihon Unisys, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • XL Group Ltd:戦略・SWOT・企業財務分析
    XL Group Ltd - Strategy, SWOT and Corporate Finance Report Summary XL Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • WellSky Corp:企業の戦略的SWOT分析
    WellSky Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • NanoPass Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary NanoPass Technologies Ltd (NanoPass) is a medical device company that develops and commercializes intradermal delivery solutions for vaccines and drugs. The company's product include MicronJet600 needle, a single use microneedles based device for intradermal delivery. Its micronjet microneed …
  • Nintendo Co Ltd (7974):企業の財務・戦略的SWOT分析
    Nintendo Co Ltd (7974) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Pearson Engineering Limited:企業の戦略・SWOT・財務情報
    Pearson Engineering Limited - Strategy, SWOT and Corporate Finance Report Summary Pearson Engineering Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • PacifiCorp:発電所・企業SWOT分析
    PacifiCorp - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • Oilex Ltd (OEX):企業の財務・戦略的SWOT分析
    Summary Oilex Ltd (Oilex) is an oil and gas company that acquires, explores and develops petroleum resources. The company’s projects in Australia include STP-EPA-0106, STP-EPA-0131, and STP-EPA-0107. Its STP-EPA-0106 project is located in onshore north-western Australia. Oilex’s Indian projects are …
  • Kirby Corporation:企業の戦略・SWOT・財務情報
    Kirby Corporation - Strategy, SWOT and Corporate Finance Report Summary Kirby Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Dentsu Inc. (4324):企業の財務・戦略的SWOT分析
    Dentsu Inc. (4324) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆